• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, May 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Professor Fatima Cardoso wins Advanced Breast Cancer Award

Bioengineer by Bioengineer
October 29, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Champalimaud Clinical Centre, Lisbon, Portugal

The European School of Oncology (ESO), together with the Advanced Breast Cancer Global Alliance, will be awarding their 2019 Advanced Breast Cancer Award to Professor Fatima Cardoso, Director of the Breast Unit of the Champalimaud Clinical Centre in Lisbon, Portugal, “in recognition of her foresight in understanding the importance of advanced breast cancer and for launching a Global Alliance against it”.

Professor Larry Norton, Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center (MSK) in New York City (USA), will present Prof Cardoso with the award on Thursday 14 November at the start of the Advanced Breast Cancer Fifth International Consensus Conference (ABC5) in Lisbon. [1]

Recognising that advanced breast cancer was a disease that was often neglected in favour of finding new treatments for early breast cancer, Prof Cardoso was instrumental in establishing the biennial ABC conferences, the first of which took place in 2011 in Lisbon. In 2016 she launched the ABC Global Alliance in Paris to continue the work of the conferences. Since then membership has grown; currently there are 177 members (scientific institutions, patient advocacy organisations, individuals and companies) in 84 countries around the world, and in 2020 it will move from being an ESO initiative to becoming an independent organisation, with ESO remaining an important member. The Alliance’s mission is:

  • to improve and extend the lives of women and men living with ABC in all countries worldwide and to fight for a cure
  • to raise awareness of advanced breast cancer and lobby worldwide for the improvement of the lives of ABC patients.

Prof Cardoso said: “I am deeply honoured to receive this award, not on my behalf but on behalf of the ABC Global Alliance and on behalf of all patients with advanced breast cancer around the world. It is for them and with them that we work. Every day I am humbled and inspired by their strength, courage and dedication.”

###

[1] ABC5 Award and lecture: “Making a difference for advanced breast cancer patients,” by Fatima Cardoso, 14.20 hrs CET, Thursday 14 November.

Media Contact
Emma Mason
[email protected]

Tags: Breast CancercancerDeath/DyingGerontologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact — Medicine

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact

May 13, 2026

Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)

May 13, 2026

Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds

May 12, 2026

Immune Protein Identified as Potential Target to Slow Parkinson’s Disease Progression

May 12, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    728 shares
    Share 290 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact

Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)

Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.